Global X Genomics & Biotechnology ETF — new fund registration

Global X Funds registered 1 new fund series on Form 485APOS, filed 2018-05-25. Featured series: Global X Genomics & Biotechnology ETF.

Registration

• Registrant / trust: Global X Funds
• CIK: 0001432353
• Form: 485APOS
• Filed: 2018-05-25
• Accession: 0001628280-18-007198
• Reported net assets: $55.8M

Series & classes (1)

Fees (from the effective prospectus)

• 12b-1 fee: 0.00%
• Gross expense ratio: 0.50%
• Management fee: 0.50%
• Net expense ratio: 0.68%
• Other expenses: 0.00%

Investment objective

The Global X Genomics & Biotechnology ETF ("Fund") seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("Underlying Index").

Advisers

• Global X Management Company LLC (Advisor)

Other filings by this registrant (15)

• 485APOS — 2026-07-27 (1 new series)
• 485APOS — 2026-07-27 (1 new series)
• 485APOS — 2026-07-13 (1 new series)
• 485APOS — 2026-07-10 (1 new series)
• 485APOS — 2026-06-26 (1 new series)
• 485APOS — 2026-06-02 (1 new series)
• 485APOS — 2026-05-22
• 485APOS — 2026-03-11 (1 new series)
• 485APOS — 2026-01-13 (1 new series)
• 485APOS — 2025-12-29 (1 new series)
• 485APOS — 2025-12-15 (1 new series)
• 485APOS — 2025-12-15

More

• Registrant profile: Global X Funds
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search